 Repeated administration of mCPP to humans might result in decreased food intake and weight loss.mCPP is used as a prototype research tool for drug discovery of selective 5-HT2C receptor agonists.The 5-HT2C receptors are G protein–coupled receptors that are coupled to phospholipase C (PLC) via Gαq, phospholipase A2 (PLA2), and possibly Gα13.